Max Planck Institute for Infection Biology

Max­Planck­Research Magazine

Issue 2016

MaxPlanckResearch 1/2016

An Artist in Gene Editing

Sometimes a single discovery can change a whole life. For Emmanuelle Charpentier, deciphering the functioning of an enzyme previously known only to experts was such a moment. The trio comprised of one enzyme and two RNA molecules and known as CRISPR-Cas9 made headlines far beyond the world of science. Since then, a lot of things have changed in the French woman’s life. She became a Director at the Berlin-based Max Planck Institute for Infection Biology in early October 2015.

Issue 2013

MaxPlanckResearch 4/2013

In the Shadow of Tuberculosis
At the Max Planck Institute for Infection Biology in Berlin, the focus is on such unpleasant companions as chlamydia, HIV and tubercle bacilli. Stefan H. E. Kaufmann, as Founding Director, helped establish it 20 years ago. Since then, the scientist has been researching the strengths and weaknesses of the tubercle bacillus. Modern tuberculosis research would be inconceivable without him – and he without it.
Issue 2011

MPR 1 /2011

The Tangled NETs of the Immune System
White blood cells that cast net-like structures to ensnare pathogens recently gave scientists quite a surprise. Now the first patients are reaping the benefits of this discovery.
Issue 2009

MPR 2 /2009

The Sabotage of Cell Logistics
The bacterium Chlamydia trachomatis uses a trick to ensure its survival within its host cell. There, it exploits the cell’s distribution center.
Go to Editor View